First trimester serum markers to predict preeclampsia

Wiener Medizinische Wochenschrift

Volumn 162, Issue 9-10, 2012, Pages 191-195

  Huppertz, Berthold ^a   Kawaguchi, Rie ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Placental growth factor; Placental protein 13; PLGF; PP13; Prediction; Preeclampsia

Indexed keywords

ENDOGLIN; PLACENTA PROTEIN; PLACENTA PROTEIN 13; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CELL MATURATION; CIRCULATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; FREEZE THAWING; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPETENT CELL; LIMIT OF DETECTION; MATERNAL BLOOD; OOCYTE MATURATION; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST;

ANTIGENS, CD; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; GALECTINS; HUMANS; INFANT, NEWBORN; MEMBRANE PROTEINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84863686943     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-012-0072-5     Document Type: Article

References (28)

1. Cetin I, Huppertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta, 32(Suppl):S4-16, 2011.
2. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, 2002. American College of Obstetricians and Gynecologists. ACOG Committee on Obstetric Practice. Int J Gynaecol Obstet, 77:67-75, 2002.
3. World Health Organization. Make Every Mother and Child Count. World Health Report, 2005. Geneva, Switzerland: World Health Organization; 2005.
4. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension, 51:970-975, 2008. (Pubitemid 351398986)
5. Gonen R, Shahar R, Grimpel YI, et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG, 115:1465-1472, 2008.
6. Huppertz B, Sammar M, Chefetz I, et al. Longitudinal determination of serum PP13 during development of preeclampsia. Fetal Diagn Therapy, 24:230-236, 2008.
7. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta, 29(Suppl A):S73-S77, 2008.
8. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta, 27:56-61, 2006. (Pubitemid 41662880)
9. Hamad RR, Bremme K, Kallner A, et al. Increased levels of an apoptotic product in the sera from women with pre-eclampsia. Scand J Clin Lab Invest, 69:204-208, 2009.
10. Gupta AK, Rusterholz C, Huppertz B, et al. A comparative study of the effect of three different syncytiotrophoblast microparticles preparations on endothelial cells. Placenta, 26:59-66, 2005. (Pubitemid 40123677)
11. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science, 308:1592-1594, 2005. (Pubitemid 40807500)
12. Giguère Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem, 56:361-375, 2010.
13. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. A meta-analysis. Obstet Gynecol, 116:401-404, 2010.
14. Clark DE, Smith SK, Licence D, et al. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol, 159:459-467, 1998. (Pubitemid 29003021)
15. Burton GJ, Watson AL, Hempstock J, et al. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab, 87:2954-2959, 2002. (Pubitemid 34655369)
16. Moser G, Gauster M, Orendi K, et al. Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models. Hum Reprod, 25:1127-1136, 2010.
17. Pan P, Fu H, Zhang L, et al. Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biol, 11:36, 2010.
18. Akolekar R, Zaragoza E, Poon LC, et al. Maternal serum placental growth factor at 11-0 to 13 -6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol, 32:732-739, 2008.
19. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 350:672-683, 2004. (Pubitemid 38364626)
20. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med, 21:9-23, 2008.
21. Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol, 195:255-259, 2006. (Pubitemid 43927517)
22. Stepan H, Krämer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab, 92:2831-2834, 2007. (Pubitemid 47037397)
23. Cowans NJ, Stamatopoulou A, Matwejew E, et al. First-trimester placental growth factor as a marker for hypertensive disorders and SGA. Prenat Diagn, 30:565-570, 2010.
24. Than NG, Romero R, Goodman M, et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci USA, 106:9731-9736, 2009.
25. Sekizawa A, Purwosunu Y, Yoshimura S, et al. PP13 mRNA expression in trophoblasts from preeclamptic placentas. Reprod Sci, 16:408-413, 2009.
26. Cowans NJ, Stamatopoulou A, Khalil A, et al. PP13 as a marker of preeclampsia: a two platform comparison study. Placenta, 32(Suppl):S37-S41, 2011.
27. Cowans NJ, Stamatopoulou A, Jaakohuhta S, et al. PP13 stability in first trimester maternal serum and whole blood. Prenat Diagn, 30:582-585, 2010.
28. Cowans NJ, Alfthan H, Stenman UH, et al. Stability of first trimester placental growth factor in serum and whole blood. Prenat Diagn, 31:1193-1197, 2011.